BackAmphastar Pharmaceuticals Overview

Amphastar Pharmaceuticals Gross Profit

Gross Profit analysis for AMPH.

Quarterly Gross Profit

$70.32M
↓ 17.51% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$341.13M
↓ 6.77% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin